{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:18:07Z","timestamp":1648628287784},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ijcard.2014.03.095","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T05:07:20Z","timestamp":1395464840000},"page":"349-350","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Up-front combination therapy in pulmonary arterial hypertension: From clinical trials to \u2018real world\u2019 observational studies"],"prefix":"10.1016","volume":"173","author":[{"given":"Juan C.","family":"Grignola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.03.095_bb0005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2011.06.021","article-title":"Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension","volume":"108","author":"Fox","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/FJC.0b013e318262a793","article-title":"Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis","volume":"60","author":"Zhu","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl.","key":"10.1016\/j.ijcard.2014.03.095_bb0015","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Galie","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"Primary pulmonary hypertension study group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2","volume":"24","author":"Humbert","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study","volume":"31","author":"Kemp","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09059180.00006413","article-title":"New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension","volume":"22","author":"Preston","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijcard.2013.12.313","article-title":"Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry","volume":"172","author":"Bergot","year":"2014","journal-title":"Int J Cardiol"},{"issue":"Suppl.","key":"10.1016\/j.ijcard.2014.03.095_bb0050","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl.","key":"10.1016\/j.ijcard.2014.03.095_bb0055","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension. Epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2014.03.095_bb0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","article-title":"Why we need observational studies to evaluate the effectiveness of health care","volume":"312","author":"Black","year":"1996","journal-title":"BMJ"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314005312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314005312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T20:52:02Z","timestamp":1538772722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314005312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0167527314005312"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.095","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up-front combination therapy in pulmonary arterial hypertension: From clinical trials to \u2018real world\u2019 observational studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}